These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11520327)

  • 1. Polycystic ovarian syndrome in women with epilepsy: a review.
    Duncan S
    Epilepsia; 2001; 42 Suppl 3():60-5. PubMed ID: 11520327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the association between valproate and polycystic ovary syndrome.
    Genton P; Bauer J; Duncan S; Taylor AE; Balen AH; Eberle A; Pedersen B; Salas-Puig X; Sauer MV
    Epilepsia; 2001 Mar; 42(3):295-304. PubMed ID: 11442143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy.
    Hu X; Wang J; Dong W; Fang Q; Hu L; Liu C
    Epilepsy Res; 2011 Nov; 97(1-2):73-82. PubMed ID: 21820873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy.
    Stephen LJ; Kwan P; Shapiro D; Dominiczak M; Brodie MJ
    Epilepsia; 2001 Aug; 42(8):1002-6. PubMed ID: 11554885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluate the effects of antiepileptic drugs on reproductive endocrine system in newly diagnosed female epileptic patients receiving either Valproate or Lamotrigine monotherapy: A prospective study.
    Sidhu HS; Srinivasa R; Sadhotra A
    Epilepsy Res; 2018 Jan; 139():20-27. PubMed ID: 29144993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the association between valproate and polycystic ovary syndrome: a response and an alternative view.
    Isojärvi JI; Taubøll E; Tapanainen JS; Pakarinen AJ; Laatikainen TJ; Knip M; Myllylä VV
    Epilepsia; 2001 Mar; 42(3):305-10. PubMed ID: 11442144
    [No Abstract]   [Full Text] [Related]  

  • 7. Valproate and the polycystic ovarian syndrome: final thoughts.
    Herzog AG; Schachter SC
    Epilepsia; 2001 Mar; 42(3):311-5. PubMed ID: 11442145
    [No Abstract]   [Full Text] [Related]  

  • 8. Polycystic ovary syndrome in women using valproate: a review.
    Bilo L; Meo R
    Gynecol Endocrinol; 2008 Oct; 24(10):562-70. PubMed ID: 19012099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate-Induced Polycystic Ovary Syndrome in a Girl with Epilepsy: A Case Study.
    Kawakami Y; Fujii S; Ishikawa G; Sekiguchi A; Nakai A; Takase M
    J Nippon Med Sch; 2018; 85(5):287-290. PubMed ID: 30464147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term reproductive endocrine health in young women with epilepsy during puberty.
    Mikkonen K; Vainionpää LK; Pakarinen AJ; Knip M; Järvelä IY; Tapanainen JS; Isojärvi JI
    Neurology; 2004 Feb; 62(3):445-50. PubMed ID: 14872028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of valproic acid on reproductive endocrine functions in Turkish women with epilepsy.
    Gorkemli H; Genc BO; Dogan EA; Genc E; Ozdemir S
    Gynecol Obstet Invest; 2009; 67(4):223-7. PubMed ID: 19246930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium valproate, hyperandrogenism and altered ovarian function in Indian women with epilepsy: a prospective study.
    Prabhakar S; Sahota P; Kharbanda PS; Siali R; Jain V; Lal V; Khurana D
    Epilepsia; 2007 Jul; 48(7):1371-7. PubMed ID: 17441994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary syndrome and epilepsy: a review of the evidence.
    Meo R; Bilo L
    Drugs; 2003; 63(12):1185-227. PubMed ID: 12790692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of anticonvulsant medication on ovarian function in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy.
    Betts T; Yarrow H; Dutton N; Greenhill L; Rolfe T
    Seizure; 2003 Sep; 12(6):323-9. PubMed ID: 12915077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report.
    Rasgon NL; Altshuler LL; Gudeman D; Burt VK; Tanavoli S; Hendrick V; Korenman S
    J Clin Psychiatry; 2000 Mar; 61(3):173-8. PubMed ID: 10817101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
    Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G
    J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of women with epilepsy who developed polycystic ovary syndrome owing to the therapy with valproate sodium].
    Minagawa K; Watanabe T; Oyanagi R
    No To Hattatsu; 2013 Jul; 45(4):304-8. PubMed ID: 23951943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between polycystic ovary syndrome and antiepileptic drugs: a review of the evidence.
    Rasgon N
    J Clin Psychopharmacol; 2004 Jun; 24(3):322-34. PubMed ID: 15118487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epilepsy and polycystic ovary syndrome: where is the link?
    Bilo L; Meo R
    Neurol Sci; 2006 Sep; 27(4):221-30. PubMed ID: 16998724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovary syndrome in patients with epilepsy: a study in 102 Chinese women.
    Zhou JQ; Zhou LM; Chen LJ; Han JD; Wang Q; Fang ZY; Chen ZY; Ling S
    Seizure; 2012 Nov; 21(9):729-33. PubMed ID: 22944116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.